Уноси

• Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow? (2024-03)

  Miljic D, S. Pekic, M. Dokic, M. Stojanovic, S. Ilić, M. Nikolić Đurović, Z. Jeumović, T. MIlojević, M. Miličević, M. Jovanović, M. Medić Stojanoska, B. Caric, N. Radić, S. Medenica, E. Manojlovic Gacic, M. Petakov, Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?, ENDOCRINE JOURNAL, Vol. 71, No. 3, pp. 285 - 293, Mar, 2024

• Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients (2020)

  T. Kovačević, B. Miljkovic, P. Kovačević, S. Dragic, D. Momcicevic, S. Avram, M. Jovanovic, K. Vucicevic, Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients, JOURNAL OF CRITICAL CARE, pp. 116 - 121, 2020

• Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients (2020-06)

  T. Kovačević, B. Miljkovic, P. Kovačević, S. Dragić, D. Momčičević, S. Avrama, M. Jovanovic, K. Vucicevic, Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients, JOURNAL OF CRITICAL CARE, Vol. 55, pp. 116 - 121, Jun, 2020

• Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice (2021-08)

  M. Roganović, A. Homšek, M. Jovanović, V. Topić Vučenović, M. Ćulafić, B. Miljković, K. Vučićević, Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice, Arhiv za farmaciju, Vol. 71, No. 4, pp. 336 - 353, Aug, 2021